Equitec Proprietary Markets’s Kezar Life Sciences KZR Stock Holding History

Equitec Proprietary Markets’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,500	Closed	-$145K	–	108
2026 Q1	$145K	Buy	+19,500	New	+$127K	0.08%	44

Equitec Proprietary Markets's KZR Position: Q2 2026 in Review

Equitec Proprietary Markets sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 19,500 shares — an estimated $145K sold.

Equitec Proprietary Markets first reported a position in KZR in Q1 2026 and held it in 1 quarter. The position peaked at $145K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Equitec Proprietary Markets reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Equitec Proprietary Markets sold 19,500 Kezar Life Sciences shares in Q2 2026, an estimated $145K.
Equitec Proprietary Markets first reported a position in Kezar Life Sciences in Q1 2026 and held it in 1 quarter.
Equitec Proprietary Markets's Kezar Life Sciences position peaked at $145K in Q1 2026.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Equitec Proprietary Markets's 13F filing for Q2 2026, filed 20 Jul 2026.